EIF2B5 p.Cys571Phe
c.1712G>T · rs375421867 · VCV902384
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1982 | likely benign |
|---|---|---|
| REVEL | 0.382 | indeterminate |
| SaProt | LLR -7.87 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.9, phastCons 1 |
| Regional constraint | o/e 0.84 | unconstrained · MANE · 8,264 bp · p 4.1e-06 · regional, not allelic |
| Overall | ||
| CADD | 23.6 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.0114% | 8,805 |
| Remaining individualsnot grpmax-eligible | 0.0032% | 31,239 |
| African / African-American | 0.00267% | 37,467 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EIF2B5
- Protein
- p.Cys571Phe
- Coding
- c.1712G>T
- MANE Select
- NM_003907
- dbSNP
- rs375421867
- Type
- single nucleotide variant
- Location
- chr3:184143109 (GRCh38)
- Gene constraint
- LOEUF 0.544 · pLI 0.16 (gnomAD)
- Structure
- AlphaFold pLDDT 79.35 · 37 PDB
- Residue 571
- an α-helix; the w2 domain
Disease context
leukoencephalopathy with vanishing white matter — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor CACH syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood
Similar variants
- EIF2B5 p.Cys571Tyr Uncertain significance ★ ⚠ same residue
- EIF2B5 p.Cys571= Likely benign ★ same residue
- EIF2B5 p.Ala403Val Pathogenic/Likely pathogenic ★★ ⚠ same condition
- EIF2B5 p.Arg113Cys Pathogenic/Likely pathogenic ★★ ⚠ same condition
- EIF2B5 p.Arg113His Pathogenic ★★ ⚠ same condition
- EIF2B5 p.Arg121Ter Pathogenic/Likely pathogenic ★★ same condition
- EIF2B5 p.Arg136His Pathogenic ★★ same condition
- EIF2B5 p.Arg195His Pathogenic ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/eif2b5-p-cys571phe (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown